Covid-19 roundup: Pfizer, BioNTech study suggest vaccine works against variants; Researchers say Sinovac's vaccine is 78% effective
Amid heightened concerns about new, largely unknown variants of SARS-CoV-2 that appear to spread more rapidly, Pfizer and BioNTech say they have preliminary evidence that …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
